1. Tokuo, Hiroshi. . Myosin X. In Advances in experimental medicine and biology, 1239, 391-403. doi:10.1007/978-3-030-38062-5_17. https://pubmed.ncbi.nlm.nih.gov/32451868/
2. Mayca Pozo, Franklin, Geng, Xinran, Tamagno, Ilaria, Cheney, Richard E, Zhang, Youwei. 2021. MYO10 drives genomic instability and inflammation in cancer. In Science advances, 7, eabg6908. doi:10.1126/sciadv.abg6908. https://pubmed.ncbi.nlm.nih.gov/34524844/
3. Yu, Huali, Lai, Mingming, Guo, Yuguang, Wang, Xingzhi, Zhu, Xiaojuan. 2014. Myo10 is required for neurogenic cell adhesion and migration. In In vitro cellular & developmental biology. Animal, 51, 400-7. doi:10.1007/s11626-014-9845-z. https://pubmed.ncbi.nlm.nih.gov/25491426/
4. Yu, Huali, Wang, Nannan, Ju, Xingda, Wang, Xingzhi, Zhu, Xiaojuan. 2012. PtdIns (3,4,5) P3 recruitment of Myo10 is essential for axon development. In PloS one, 7, e36988. doi:10.1371/journal.pone.0036988. https://pubmed.ncbi.nlm.nih.gov/22590642/
5. Wang, Xiqian, Li, Jing, Xu, Xiao, Zheng, Jiachun, Li, Qingbo. 2018. miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 103, 1312-1318. doi:10.1016/j.biopha.2018.04.153. https://pubmed.ncbi.nlm.nih.gov/29864913/
6. He, Jian-Hui, Chen, Jian-Guo, Zhang, Bin, Xu, Jia-Wen, Chen, Le. . Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer. In Technology in cancer research & treatment, 19, 1533033820936773. doi:10.1177/1533033820936773. https://pubmed.ncbi.nlm.nih.gov/32618228/
智鼠故事 
